Out-licensing: Diagnostic/Genetic diagnostics & Blood and forming organs

Latest: Watch here for details of new products and services.

About Us: Pharmalicensing - Open Innovation for the life sciences
Our Products: Overview; Partnering Search; Company Profiling; Partneringtools; Reports; Partnering Consulting; Due Diligence; Comparison
Due Diligence: Overview; Top Applications; Online Panel Discussions; Request Consultation
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire; Jobs; Forums
Contact Pharmalicensing: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Pharmalicensing Ltd
is a division of

Up-to-date access to technology licensing opportunities worldwide.

Displaying 1..2 of 2 - per page
Order by

Blood genetic marker for predicting restenosis after the use of heart stents More

Biomarker for the detection of deep vein thrombosis, stroke and myocardial infarction More

Displaying 1..2 of 2 - per page
Order by

Therapeutic target: Blood composition; Blood disorders; Blood substitute; Blood Transfusion; Fibrogenesis; Hemorrhagic trauma; Lymphatic disorders; Sepsis; Thrombosis; Whole blood substitute
Development phase: Early Stage; Preclinical; Phase I; Phase I/II; Phase II; Phase III; Phase III/IV; Preregistration; Registered

Industry news: Pharmalicensing provides comprehensive industry coverage.